<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 6 Issue 3</issue_number>
<issue_period>2015 (July - September)</issue_period>
<title>STUDY OF RISK FACTORS, CHEST X-RAY FINDINGS, AETIOLOGICAL AGENTS AND THEIR SENSITIVITY PATTERN AMONG PATIENTS WITH LOWER RESPIRATORY TRACT INFECTION </title>
<abstract>Respiratory tract infections are the most common infectious disease in humans. It is the leading cause of mortality and morbidity in critically ill patients in developing countries.The aim of the present study was to evaluate the risk factors, chest x ray findings, aetiological agents and their antimicrobial susceptibility pattern in hospitalized patients with lower respiratory tract infection. A total of 200 sputum samples collected and processed. Organisms were identified and antimicrobial susceptibility of bacterial isolates was performed using standard procedures. Of the 200 samples 87 yielded growth.  lessThan i greaterThan Pseudomonas aeruginosa lessThan /i greaterThan  was the predominant isolate followed by  lessThan i greaterThan Klebsiella  lessThan /i greaterThan  lessThan i greaterThan pneumoniae,  lessThan /i greaterThan  lessThan i greaterThan Staphylococcus aureus lessThan /i greaterThan . Antibiotic susceptibility pattern showed that carbapenem, aminoglycosides and fluroquinolones are most effective against Gram negative bacteria. Glycopeptide,macrolides and fluroquinolones effective against Gram positive bacteria. Hence regular monitoring of the changing trends of prevalent strains and their antimicrobial susceptibility patterns is required for the good management of patients.</abstract>
<authors>SHARADADEVI MANNUR, ARCHANA BR, SHUBHAKARA K AND NAGARAJ ER</authors>
<keywords>Lower respiratory tract infection, sputum, antimicrobial susceptibility, drug resistance

</keywords>
<pages>336-341</pages>
</article>
</Journal>
